licensing

China’s biopharma market strikes $30b in oncology licensing offers

In 2024, antibody-drug conjugates controlled the licensing project. China’s biopharmaceutical market has actually seen a sharp surge in oncology medication licensing arrangements in 2024, specifically monoclonal antibodies (MABS) and antibody-toxin…

June 6, 2025

Asia Business News (ISSN: 3079-8531) is a leading international business publication dedicated to delivering in-depth analysis, expert insights, and comprehensive coverage of economic trends, corporate developments, and market dynamics across the Asia-Pacific region and beyond. With a commitment to journalistic integrity and analytical rigor, Asia Business News serves as a trusted source of information for business leaders, policymakers, and investors seeking authoritative perspectives on global commerce, finance, and industry advancements.

China’s biopharma market strikes $30b in oncology licensing offers

Gov’ t to turn out licensing routine for facilities and SPCs

United States to Rejig Export Curbs for AI Chips, ‘Change to Licensing Bargains’

Impressive Mobile First Website Builder

United States to Rejig Export Curbs for AI Chips, ‘Change to Licensing Bargains’

Disa system inks certifying contract to commercialise cataract testing gadget

Indonesia to reduce licensing, deal motivations for United States business

About Company